Trial
NCT01655186
A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes Mellitus
Phase IIWITHDRAWNSAFETYConfidence: HIGH
Sponsor
Biogen
Collaborators
—
Condition
Renal Insufficiency, Chronic
Intervention
Bardoxolone Methyl
Why stopped
IDMC recommendation for safety concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-29